Ipsen is a global mid-sized biopharmaceutical group specializing in transformative medicines in oncology, rare diseases, and neurosciences. With nearly 100 years of experience and hubs in the US, France, and UK, the company has passionate teams in over 40 countries and brings medicines to patients in 88 countries.